It’s time for the government to enter the generic drug business.

The story that the Kremlin was secretly investing in American tech companies is about cronyism, not Russiagate

How did Thailand's effort to ensure cheap AIDS drugs become a supposed outsourcing scandal?

It sounds refreshing, certainly, but the Devil is in the details

Pharmaceutical giants are finally bending to worldwide public pressure on AIDS drugs, but we're still victims of their profiteering.

President Obama threatens his legacy by continuing the Bush approach to healthcare and retirement security

Donors hope to get $30 a pop for their plasma, but sometimes they aren't even paid what they're promised

One group of people can be trusted to steer through hyper-partisanship and corporate self-interest

Historian Maureen Ogle defends the oft-criticized meat industry -- and suggests some foodies have it all wrong

While profits soar, wages continue to stagnate and anti-tax zealots gut the safety net — a recipe for disaster

Salon talks to author Beth Macy about the economics, regulatory failures and racism that fueled the opioid crisis

When federal land becomes state land, it can be bought and sold to the profit of small-government billionaires

A landmark ruling against Novartis highlights practices that make healthcare unaffordable in developing countries

The U.S. spends more on drugs than any other developed nation. Why is that so hard to fix?

Some schools feast on federal aid and don't care if the student can repay it. Here's one woman's tragic story